Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05538832 · ClinicalTrials.gov registry record · Early Phase 1

Remote State Representation in Early Psychosis

A Early Phase 1 study, sponsored by University of Minnesota.

Completed
Registry status
Early Phase 1
Development phase
152
Enrollment target

NCT05538832 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 152 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05538832, a Early Phase 1 study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
Early Phase 1
Development phase
152 participants
Enrollment target

Study Summary

The purpose of this study is to examine state representation in individuals aged 18-30 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete some observational tests as well as a cognitive training clinical trial.

Interventions

  • DEVICE BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm
  • DEVICE BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2022-07-27
Est. Completion 2025-09-30
Phase Early Phase 1

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05538832

The ClinicalTrials.gov registry entry for NCT05538832 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm is the first listed.

NCT05538832 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05538832 about?

NCT05538832 is a clinical study titled "Remote State Representation in Early Psychosis". The purpose of this study is to examine state representation in individuals aged 18-30 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigato...

What is the current status of trial NCT05538832?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 152 participants. The study started on 2022-07-27. Estimated completion is 2025-09-30.

What interventions are being tested in trial NCT05538832?

The interventions under investigation include: BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm (DEVICE), BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm (DEVICE).

Who is sponsoring clinical trial NCT05538832?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.